Loading
Latest filing published 13 Sept 2006 for HEMOBIOTECH INC, €15k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Robert Baron is a declared insider of Hemobiotech Inc, with filings sourced from SEC (Form 4). The record holds 5 filings, for trades running from 23 February 2006 to 13 July 2006.
Purchases make up the whole of the open-market record (3 purchases, €16k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants.
The median purchase comes to €4,532.
The newest entry dates from 16 March 2007: a share grant of €15k, in Hemobiotech Inc. The last purchase on record was published on 21 March 2006, which is 7,522 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations